FAKTOR OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 01:20:23 29/06/2024 am IST | ||
| 0.4 EUR | -2.44% |
|
| Current month | +5.26% | ||
| 1 month | +8.11% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 0.4 | -2.44% |
| 27/24/27 | 0.41 | -6.82% |
| 26/24/26 | 0.44 | +2.33% |
| 25/24/25 | 0.43 | 0.00% |
| 24/24/24 | 0.43 | +4.88% |
Delayed Quote Deutsche Boerse AG
Last update June 29, 2024 at 01:20 am IST
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PE4BMY |
| ISIN | DE000PE4BMY1 |
| Date issued | 07/04/2022 |
| Strike | 41.51 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.46 € |
|---|---|
| Lowest since issue | 0.35 € |
| Spread | 0.01 € |
| Spread % | 2.44% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.53
USD
Average target price
53.19
USD
Spread / Average Target
+28.09%
- Stock Market
- Certificates
- Certificat
